General Information of DTT (ID: TTEAID7)

DTT Name Trypanosoma Cruzipain (Trypano CYSP) DTT Info
Gene Name Trypano CYSP

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Approved Drug(s)
Clinical Trial Drug(s)
Discontinued Drug(s)
Investigative Drug(s)
1 Approved Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
TRICLABENDAZOLE DMPWGBR Helminth infection 1F90.0 Approved [1]
------------------------------------------------------------------------------------
1 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
MANIDIPINE DMJPGUA N. A. N. A. Phase 3 [1]
------------------------------------------------------------------------------------
1 Discontinued Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
L-755507 DMPWBNU N. A. N. A. Terminated [2]
------------------------------------------------------------------------------------
27 Investigative Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
(3Z)-1H-indole-2,3-dione 3-thiosemicarbazone DMI9N8G Discovery agent N.A. Investigative [3]
1-(1-(3-nitrophenyl)propylidene)thiosemicarbazide DM0XNMP Discovery agent N.A. Investigative [4]
1-(3,4-dihydronaphthalen-1-yl)ethanone DM5C7I8 Discovery agent N.A. Investigative [4]
1-(3-Methoxy-benzyl)-5-methyl-1H-indole-2,3-dione DM30M9H Discovery agent N.A. Investigative [3]
1-(bis(3-bromophenyl)methylene)thiosemicarbazide DMTZ71K Discovery agent N.A. Investigative [4]
2-(cycloheptylamino)-2-oxoethyl 2-aminonicotinate DMQ9ODG Discovery agent N.A. Investigative [5]
2-(trifluoromethyl)benzaldehyde thiosemicarbazone DMWAKFM Discovery agent N.A. Investigative [6]
2-methoxy-1-naphthaldehyde thiosemicarbazone DMH76C5 Discovery agent N.A. Investigative [6]
3',4'-dichloroacetophenonethiosemicarbazone DMS1QIJ Discovery agent N.A. Investigative [7]
3'-bromopropiophenonethiosemicarbazone DMK7D8N Discovery agent N.A. Investigative [7]
3,4-dichlorobenzaldehyde thiosemicarbazone DMUSPIC Discovery agent N.A. Investigative [6]
3,5-dichlorobenzaldehyde thiosemicarbazone DMPVI9W Discovery agent N.A. Investigative [6]
3-(trifluoromethyl)benzaldehyde thiosemicarbazone DM2YVA1 Discovery agent N.A. Investigative [6]
3-amino-5-(furan-2-yl)biphenyl-2,4-dicarbonitrile DM6Y2KW Discovery agent N.A. Investigative [2]
3-chloro-N-(4-(phenyldiazenyl)phenyl)benzamide DMBVCLY Discovery agent N.A. Investigative [2]
5-(3,4-dichlorophenyl)-1H-pyrazol-3-ol DMRF0PS Discovery agent N.A. Investigative [2]
5-(4-bromophenyl)-2-furaldehyde thiosemicarbazone DMT4856 Discovery agent N.A. Investigative [6]
5-Chloro-1-(4-chloro-benzyl)-1H-indole-2,3-dione DMIH7W1 Discovery agent N.A. Investigative [3]
Benzoyl-Arginine-Alanine-Methyl Ketone DMC7TNF Discovery agent N.A. Investigative [8]
GNF-PF-4478 DMCDU8K Discovery agent N.A. Investigative [9]
K-777 DMIFCMW Discovery agent N.A. Investigative [10]
N1,N4-bis(5-chloro-2-methylphenyl)succinamide DMRO7JX Discovery agent N.A. Investigative [2]
Vinylsulphones DMNFVO7 Infection of P. falciparum 1F40 Investigative [11]
VITAMIN K2 DMJB3E1 Discovery agent N.A. Investigative [1]
WRR-112 DMP761U Discovery agent N.A. Investigative [8]
WRR-204 DMRVAH1 Discovery agent N.A. Investigative [8]
WRR-99 DM8ZA6K Discovery agent N.A. Investigative [8]
------------------------------------------------------------------------------------
⏷ Show the Full List of 27 Investigative Drug(s)
Molecule Interaction Atlas

References

1 Colloid formation by drugs in simulated intestinal fluid. J Med Chem. 2010 May 27;53(10):4259-65.
2 Quantitative analyses of aggregation, autofluorescence, and reactivity artifacts in a screen for inhibitors of a thiol protease. J Med Chem. 2010 Jan 14;53(1):37-51.
3 Synthesis and evaluation of isatins and thiosemicarbazone derivatives against cruzain, falcipain-2 and rhodesain. Bioorg Med Chem Lett. 2003 Oct 20;13(20):3527-30.
4 Design, synthesis, and biochemical evaluation of novel cruzain inhibitors with potential application in the treatment of Chagas' disease. Bioorg Med Chem Lett. 2006 Aug 15;16(16):4405-9.
5 Divergent modes of enzyme inhibition in a homologous structure-activity series. J Med Chem. 2009 Aug 27;52(16):5005-8.
6 Synthesis and structure-activity relationship study of potent trypanocidal thio semicarbazone inhibitors of the trypanosomal cysteine protease cruz... J Med Chem. 2002 Jun 20;45(13):2695-707.
7 Studies toward the structural optimization of novel thiazolylhydrazone-based potent antitrypanosomal agents. Bioorg Med Chem. 2010 Nov 15;18(22):7826-35.
8 How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6.
9 Complementarity between a docking and a high-throughput screen in discovering new cruzain inhibitors. J Med Chem. 2010 Jul 8;53(13):4891-905.
10 Novel non-peptidic vinylsulfones targeting the S2 and S3 subsites of parasite cysteine proteases. Bioorg Med Chem Lett. 2009 Nov 1;19(21):6218-21.
11 Opportunities and challenges in antiparasitic drug discovery. Nat Rev Drug Discov. 2005 Sep;4(9):727-40.